Sunbeam Management, LLC 3

3 · OWC Pharmaceutical Research Corp. · Filed May 11, 2020

Insider Transaction Report

Form 3
Period: 2020-03-23
Holdings
  • Common Stock

    500,000
  • Series B Convertible Preferred Stock

    Exercise: $0.00From: 2020-03-23Exp: 2030-01-01Sunbeam Management, LLC (43,675 underlying)

Documents

1 file
  • 3
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT